唾液 microRNA 和细胞因子在口腔鳞状细胞癌的诊断和预后中的作用。
Role of Salivary MicroRNA and Cytokines in the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
机构信息
Biomedical Group (BIO277), Department of Stomatology, School of Dentistry, University of Granada, 18071 Granada, Spain.
Instituto Investigación Biosanitaria, ibs.Granada, 18071 Granada, Spain.
出版信息
Int J Mol Sci. 2021 Nov 11;22(22):12215. doi: 10.3390/ijms222212215.
Abstract
Oral squamous cell carcinoma (OSCC) is the most prevalent oral malignant tumor worldwide. An early diagnosis can have a major positive impact on its prognosis. Human saliva contains cytokines, DNA and RNA molecules, circulating cells, and derivatives of tissues and extracellular vesicles, among other factors that can serve as biomarkers. Hence, the analysis of saliva may provide useful information for the early diagnosis of OSCC for its prognosis. The objective of this review was to determine the potential usefulness of salivary biomarkers (cytokines and microRNA) to diagnose OSCC and improve its prognosis. A combination of salivary miRNA and proteomic data could allow a definitive and early diagnosis to be obtained. However, there remains a need to optimize and standardize the protocols used to quantify miRNAs.
摘要
口腔鳞状细胞癌（OSCC）是全球最常见的口腔恶性肿瘤。早期诊断对其预后有重大积极影响。人类唾液中含有细胞因子、DNA 和 RNA 分子、循环细胞以及组织和细胞外囊泡的衍生物等，可以作为生物标志物。因此，唾液分析可能为 OSCC 的早期诊断及其预后提供有用信息。本综述的目的是确定唾液生物标志物（细胞因子和 microRNA）在诊断 OSCC 和改善其预后方面的潜在用途。唾液 microRNA 和蛋白质组学数据的组合可以实现明确和早期的诊断。然而，仍需要优化和标准化用于定量 microRNA 的方案。
相似文献
1
Role of Salivary MicroRNA and Cytokines in the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Int J Mol Sci. 2021 Nov 11;22(22):12215. doi: 10.3390/ijms222212215.
2
Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
J Proteomics. 2020 Feb 10;212:103574. doi: 10.1016/j.jprot.2019.103574. Epub 2019 Nov 7.
3
Identification of potential salivary biomarker panels for oral squamous cell carcinoma.
Sci Rep. 2021 Feb 9;11(1):3365. doi: 10.1038/s41598-021-82635-0.
4
Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.
Int J Mol Sci. 2021 Jun 24;22(13):6795. doi: 10.3390/ijms22136795.
5
Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Med Sci Monit. 2015 Aug 5;21:2275-81. doi: 10.12659/MSM.893925.
6
Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Head Neck Pathol. 2023 Dec;17(4):961-968. doi: 10.1007/s12105-023-01600-7. Epub 2023 Nov 28.
7
Protein Cargo of Salivary Small Extracellular Vesicles as Potential Functional Signature of Oral Squamous Cell Carcinoma.
Int J Mol Sci. 2021 Oct 16;22(20):11160. doi: 10.3390/ijms222011160.
8
Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
Cancer Prev Res (Phila). 2018 Aug;11(8):491-502. doi: 10.1158/1940-6207.CAPR-17-0409. Epub 2018 May 15.
9
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma.
Cell Physiol Biochem. 2018;47(6):2511-2521. doi: 10.1159/000491624. Epub 2018 Jul 10.
10
Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
BMC Cancer. 2018 Apr 18;18(1):439. doi: 10.1186/s12885-018-4364-z.
引用本文的文献
1
Serum from patients with oral squamous cell carcinoma remodels the tumor immune escape ecological niche by promoting regulatory T‑cell differentiation and T‑cell exhaustion.
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8978. Epub 2025 Aug 29.
2
Biosensors based on organic transistors for intraoral biomarker detection.
Mikrochim Acta. 2025 May 5;192(6):335. doi: 10.1007/s00604-025-07189-8.
3
Expression and mechanism of PRDXs family in oral squamous cell carcinoma.
Discov Oncol. 2025 Mar 28;16(1):415. doi: 10.1007/s12672-025-01872-1.
4
Salivary miRNAs and cytokines associated with diagnosis and prognosis of oral squamous cell carcinoma.
Front Cell Dev Biol. 2025 Jan 22;13:1531016. doi: 10.3389/fcell.2025.1531016. eCollection 2025.
5
Salivary diagnostics: opportunities and challenges.
Theranostics. 2024 Oct 21;14(18):6969-6990. doi: 10.7150/thno.100600. eCollection 2024.
6
Caveolin-1 modulates cisplatin sensitivity in oral squamous cell carcinoma through ferroptosis.
Clin Transl Oncol. 2025 May;27(5):2160-2173. doi: 10.1007/s12094-024-03724-w. Epub 2024 Sep 26.
7
Identification of Stage-Specific microRNAs that Govern the Early Stages of Sequential Oral Oncogenesis by Strategically Bridging Human Genetics with Epigenetics and Utilizing an Animal Model.
Int J Mol Sci. 2024 Jul 12;25(14):7642. doi: 10.3390/ijms25147642.
8
Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy.
Periodontol 2000. 2024 Oct;96(1):316-328. doi: 10.1111/prd.12567. Epub 2024 Apr 27.
9
Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance.
Int J Mol Sci. 2024 Feb 10;25(4):2167. doi: 10.3390/ijms25042167.
10
Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma.
Front Pharmacol. 2024 Jan 8;14:1302059. doi: 10.3389/fphar.2023.1302059. eCollection 2023.
本文引用的文献
1
Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential.
Front Oral Health. 2021 Feb 22;2:642238. doi: 10.3389/froh.2021.642238. eCollection 2021.
2
Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.
Int J Mol Sci. 2021 Jun 24;22(13):6795. doi: 10.3390/ijms22136795.
3
Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review.
Maxillofac Plast Reconstr Surg. 2021 Jun 30;43(1):19. doi: 10.1186/s40902-021-00303-9.
4
Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma.
J Clin Med. 2021 Apr 13;10(8):1658. doi: 10.3390/jcm10081658.
5
Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
Genes (Basel). 2021 Mar 15;12(3):422. doi: 10.3390/genes12030422.
6
The role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review.
Arch Oral Biol. 2021 May;125:105108. doi: 10.1016/j.archoralbio.2021.105108. Epub 2021 Mar 18.
7
Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
PLoS One. 2021 Mar 18;16(3):e0248167. doi: 10.1371/journal.pone.0248167. eCollection 2021.
8
Blood and Salivary MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
J Oral Maxillofac Surg. 2021 May;79(5):1082.e1-1082.e13. doi: 10.1016/j.joms.2020.12.043. Epub 2020 Dec 30.
9
The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
Cancer Med. 2020 Nov;9(22):8333-8344. doi: 10.1002/cam4.3440. Epub 2020 Oct 13.
10
Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.
Histol Histopathol. 2021 Feb;36(2):113-122. doi: 10.14670/HH-18-250. Epub 2020 Sep 28.
Zotero 插件